| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.28▲ | 0.28▲ | 0.28▲ | 0.29▼ | 0.31▼ |
| MA10 | 0.28▲ | 0.28▲ | 0.28▼ | 0.30▼ | 0.32▼ |
| MA20 | 0.28▼ | 0.29▼ | 0.29▼ | 0.32▼ | 0.47▼ |
| MA50 | 0.29▼ | 0.30▼ | 0.30▼ | 0.34▼ | 0.64▼ |
| MA100 | 0.30▼ | 0.31▼ | 0.32▼ | 0.51▼ | 0.93▼ |
| MA200 | 0.31▼ | 0.33▼ | 0.33▼ | 0.63▼ | 1.98▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.000▼ | 0.000▼ | -0.002▼ | -0.006▼ |
| RSI | 45.263▼ | 41.350▼ | 40.849▼ | 37.868▼ | 32.238▼ |
| STOCH | 67.373 | 25.653 | 19.352▼ | 8.526▼ | 25.283 |
| WILL %R | -52.406 | -62.447 | -63.223 | -88.313▼ | -88.043▼ |
| CCI | 37.048 | -33.581 | -41.336 | -116.775▼ | -77.404 |
|
Tuesday, February 17, 2026 05:06 AM
In two non-GLP studies, CUE-401 was well tolerated with no adverse events observedProof-of-concept studies reinforce promising preclinical ...
|
|
Thursday, February 12, 2026 05:41 AM
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...
|
|
Friday, December 19, 2025 12:00 AM
BOSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/02/26 | 0.292 | 0.292 | 0.272 | 0.2817 | 268,821 |
| 23/02/26 | 0.28 | 0.2895 | 0.2765 | 0.281 | 0 |
| 20/02/26 | 0.293 | 0.3029 | 0.2795 | 0.2848 | 454,927 |
| 19/02/26 | 0.3029 | 0.3029 | 0.2925 | 0.2932 | 159,087 |
| 18/02/26 | 0.2901 | 0.3028 | 0.29 | 0.2971 | 215,886 |
| 17/02/26 | 0.3029 | 0.3029 | 0.288 | 0.2911 | 486,041 |
| 13/02/26 | 0.3001 | 0.3192 | 0.295 | 0.3066 | 352,036 |
| 12/02/26 | 0.35 | 0.35 | 0.30 | 0.30 | 425,503 |
| 11/02/26 | 0.3339 | 0.3499 | 0.3177 | 0.3217 | 306,309 |
| 10/02/26 | 0.3313 | 0.355 | 0.325 | 0.3374 | 768,511 |
|
|
||||
|
|
||||
|
|